The division of neuro-oncology has a two-fold mission:
- To treat and manage patients with primary and metastatic brain tumors
- To understand the biology of brain tumors so that more effective treatments can be developed
Collaboration among expert team members, a wide range of treatment strategies, and state-of-the-art technology enable the division to provide the best possible management of patients with brain tumors.
The neuro-oncology team includes neurosurgeons, neuro-oncologists, radiation oncologists, neuropathologists, basic scientists,and nurses specially trained to care for patients with brain tumors. Treatment strategies include surgery, chemotherapy, radiation and radiosurgery, alone or in combination.
A multi-disciplinary neuro-oncology conference—also known as tumor board—is held weekly. During this conference, brain tumor cases both ordinary and extraordinary are reviewed by residents, fellows and as many as 15 different physician specialists. The purpose of these discussions is to arrive at an optimal treatment strategy for each case.
Technology used in the treatment of neuro-oncology patients includes intraoperative MRI, frameless stereotaxy system, and adjuvant therapy (local brachytherapy, immunotherapy and chemotherapy). The division’s neuro-oncology colleagues coordinate medical management and long-term follow-up.
The division’s research arm focuses on two areas: laboratory studies related to brain tumor biology and clinical trials. The clinical trials afford patients with brain tumors the opportunity to receive state-of-the-art treatment modalities that are generally available only at major teaching centers like the University of Cincinnati.
Areas of disease focus include glioblastoma and metastatic brain tumors.